UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

Nature medicine, 2021-03, Vol.27 (3), p.491-503

2021

Volltextzugriff (PDF)

The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey

Supportive care in cancer, 2021-12, Vol.29 (12), p.7591-7599

2021

Volltextzugriff (PDF)

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

Leukemia, 2021-09, Vol.35 (9), p.2727-2730

2021

Volltextzugriff (PDF)

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents

Cancers, 2021-10, Vol.13 (20), p.5141

2021

Volltextzugriff (PDF)

Nodal marginal zone lymphoma: clinical features, diagnosis, management and treatment

Best practice & research. Clinical haematology, 2017-03, Vol.30 (1-2), p.92-98

2017

Volltextzugriff (PDF)

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Haematologica (Roma), 2022-03, Vol.107 (3), p.625-634

2022

Volltextzugriff (PDF)

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy

Leukemia & lymphoma, 2015-07, Vol.56 (7), p.1949-1958

2015

Volltextzugriff (PDF)

Discordant bone marrow involvement in non-Hodgkin lymphoma

Blood, 2016-02, Vol.127 (8), p.965-970

2016

Volltextzugriff (PDF)

The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma

International journal of molecular sciences, 2023-12, Vol.25 (1), p.549

2023

Volltextzugriff (PDF)

Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway

PloS one, 2020-03, Vol.15 (3), p.e0230033-e0230033

2020

Volltextzugriff (PDF)

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients

Mayo Clinic proceedings, 2015-06, Vol.90 (6), p.756-764

2015

Volltextzugriff (PDF)

Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia

Frontiers in immunology, 2022-09, Vol.13, p.953644-953644

2022

Volltextzugriff (PDF)

Characteristics of primary splenic diffuse large B‐cell lymphoma and role of splenectomy in improving survival

Cancer, 2015-09, Vol.121 (17), p.2909-2916

2015

Volltextzugriff (PDF)

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

Haematologica (Roma), 2014-01, Vol.99 (1), p.125-130

2014

Volltextzugriff (PDF)

Overcoming the unmet need of Richter transformation: the use of pirtobrutinib

The Lancet. Haematology, 2024-09, Vol.11 (9), p.e636-e637

Tadmor, Tamar

2024

Volltextzugriff (PDF)

Time to Cure Hairy Cell Leukemia

Turkish journal of haematology, 2017-12, Vol.34 (4), p.289-290

2017

Volltextzugriff (PDF)

Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study

Annals of hematology, 2020-06, Vol.99 (6), p.1273-1281

2020

Volltextzugriff (PDF)

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy

Palliative medicine, 2021-05, Vol.35 (5), p.927-932

2021

Volltextzugriff (PDF)

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity

PloS one, 2019-01, Vol.14 (1), p.e0209024-e0209024

2019

Volltextzugriff (PDF)

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998‐2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS

HemaSphere, 2023-08, Vol.7 (S3), p.e944666d-n/a

2023

Volltextzugriff (PDF)

P1532: CLINICAL OUTCOMES OF COVID‐19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

HemaSphere, 2023-08, Vol.7 (S3), p.e96550ad-n/a

2023

Volltextzugriff (PDF)

The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia

Frontiers in immunology, 2021-02, Vol.11, p.603569-603569

2021

Volltextzugriff (PDF)

It’s time to change the standard of care for hairy cell leukemia?

Leukemia & lymphoma, 2024-07, p.1-3

2024

Volltextzugriff (PDF)

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

Cancer Immunology, Immunotherapy, 2013-01, Vol.62 (1), p.87-99

2013

Volltextzugriff (PDF)

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(201)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(171)
Life Sciences & Biomedicine
(168)
Humans
(138)
Hematology
(136)
Oncology
(95)
Female
(75)
Male
(72)
Aged
(54)
Middle Aged
(46)
Adult
(38)
Prognosis
(38)
Chronic Lymphocytic Leukemia
(34)
Retrospective Studies
(31)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(30)
Leukemia
(29)
Treatment Outcome
(28)
Aged, 80 And Over
(27)
Patients
(27)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Rituximab
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing

The impact of COVID-19 on patients with hematological malignancies: the mixed-method analysis of an Israeli national survey

Antibody persistence 100 days following the second dose of BNT162b mRNA Covid19 vaccine in patients with chronic lymphocytic leukemia

Richter Transformation in Chronic Lymphocytic Leukemia: Update in the Era of Novel Agents

Nodal marginal zone lymphoma: clinical features, diagnosis, management and treatment

Safety and efficacy of the BNT162b mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia

Richter syndrome in chronic lymphocytic leukemia: updates on biology, clinical features and therapy

Discordant bone marrow involvement in non-Hodgkin lymphoma

Hairy cell leukemia and COVID-19 adaptation of treatment guidelines

The Involvement of LAG-3positive Plasma Cells in the Development of Multiple Myeloma

Cell-free IgG-aggregates in plasma of patients with chronic lymphocytic leukemia cause chronic activation of the classical complement pathway

Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients

Increased serum level of alpha-2 macroglobulin and its production by B-lymphocytes in chronic lymphocytic leukemia

Characteristics of primary splenic diffuse large B‐cell lymphoma and role of splenectomy in improving survival

Monocyte count at diagnosis is a prognostic parameter in diffuse large B-cell lymphoma: results from a large multicenter study involving 1191 patients in the pre- and post-rituximab era

Overcoming the unmet need of Richter transformation: the use of pirtobrutinib

Time to Cure Hairy Cell Leukemia

Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study

Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy

A C5a-Immunoglobulin complex in chronic lymphocytic leukemia patients is associated with decreased complement activity

P652: IMPROVED SURVIVAL OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA BETWEEN 1998‐2022, INCLUDING THE ERA OF TARGET THERAPIES WITH BCL2 AND BTK INHIBITORS

P1532: CLINICAL OUTCOMES OF COVID‐19 IN MYCOSIS FUNGOIDES AND SEZARY SYNDROME (MF/SS)

The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia

It’s time to change the standard of care for hairy cell leukemia?

B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion

Suchergebnisse filtern